Skip to content

NuStats Lab

Active
Private limited companyfounded 2024active for 2 yearsOudenaardsesteenweg 617, 9420 Erpe-Mere, BelgiumKBO/BCE: BE 1010.533.033

From the official registers: KBO 2 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

NuStats Lab has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €91,187 and a net result of €27,759. Its solvency ranks better than 75% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 19-06-2024 Normal situation
Activity
Research and development on biotechnology NACE 72101and 1 other
Establishment unit
2.361.103.427 9420 Erpe-Mere, since 19-06-2024
Financial year end
31 December
Peppol
Reachable since 06-01-2026

Board and ownership

Board

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€73,094
▼ 15.3%
Turnover
≈ €200,000
estimated
Profit
€27,759
▼ 54.1%
Equity
€91,187
▲ 43.8%
Total assets
€118,033
▲ 38.1%
Staff
≈ 0.6 FTE
estimated
Filed on 30-06-2026, 31 days before the deadlineat the National Bank
Score breakdownraises riskFounded in 2024lowers riskLiquidity: current ratio 3.46, cash €80,078Sector: Scientific research and development (NACE 72)Equity €91,187 (77.3% of total assets)Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 82% of micro companies in research and development (NACE 72)
Financial strength · tick: 2024
Strong
Solvency 100+1
equity 77.3% of total assets
Liquidity 92+24
short-term debt 22.7% · cash 67.8%
Profitability 98-2
return on assets 23.5%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 07-2025: 0.7% 08-2025: 0.7%● unchanged vs 07-2025 09-2025: 0.7%● unchanged vs 08-2025highest value 10-2025: 0.3%▼ -0.4 percentage points vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.4%▲ +0.1 percentage points vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.3%▼ -0.1 percentage points vs 06-2026 08-2026: 0.4%▲ +0.1 percentage points vs 07-2026 09-2026: 0.5%▲ +0.1 percentage points vs 08-2026 10-2026: 0.1%▼ -0.4 percentage points vs 09-2026lowest value
Credit of up to €8,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 3.46 (2.63 in 2024), above the usual 1.5. Short-term debt is 22.7% and cash 67.8% of total assets. 22.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 81% on liquidity, 79% on profitability and 86% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 3.46, cash €80,078
NBB · annual accounts
lowers risk · Sector: Scientific research and development (NACE 72)
KBO
lowers risk · Equity €91,187 (77.3% of total assets)
NBB · annual accounts
raises risk · Founded in 2024
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
31 days early
2024
42 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 6 days after the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2024.
KBO publications

Comparable companies

These companies have the same main activity as NuStats Lab: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €85,700 and €148,000, founded in 2024.

CompanyTotal assetsGross margin
NuStats Lab Erpe-Mere€118,033€73,094
MWO Wavre€148,005€71,854
NXTLAB Roeselare€119,190€114,641
ReWrite Leuven€115,374€63,990
DOCTEUR PAOLO BATTISTI Clavier€86,909€49,431
ZOOVERY Sint-Genesius-Rode€145,109€83,823
ADBDL Médecine et Sciences médicales Wavre€85,668€64,301
Full comparison

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about NuStats Lab

What is the company number of NuStats Lab?
The company number of NuStats Lab is 1010.533.033. The VAT number is the same number with BE in front: BE 1010.533.033.
Where is NuStats Lab based?
The registered office is at Oudenaardsesteenweg 617, 9420 Erpe-Mere.Company details
What does NuStats Lab do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of NuStats Lab?
The legal form of NuStats Lab is Private limited company (BV).
When was NuStats Lab founded?
NuStats Lab was founded on 19-06-2024.
Is NuStats Lab still active?
Yes, NuStats Lab is an active enterprise in the KBO register.
What is the turnover of NuStats Lab?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €73,094 and 1,290 comparable companies of the same size. It probably lies between €130,000 and €390,000. It is a rough estimate.Financials
Is NuStats Lab profitable?
In financial year 2025, NuStats Lab made a profit of €27,759.
Where can I find the annual accounts of NuStats Lab?
NuStats Lab filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of NuStats Lab due?
NuStats Lab must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.